Head CCO Strategy at Sandoz, global leader in generic pharmaceuticals and biosimilars.
Reporting to the Chief Commercial Officer with global oversight of pipeline selection, portfolio management and strategic partnerships / acquisitions.
Former Manager at Bain, one of the world's leading strategy consultancies. Consulting experience mainly in the Healthcare & Life Science and Private Equity industries.
Global outreach with extensive and local casework in leadership roles across Europe, North America, and APAC.
Former Researcher in economics at Bruegel, consistently ranked world's #1 international economics think tank (Brussels). Specialized in the fields of Macroeconomics, Game Theory and Financial Markets with several published articles.
Previous work experiences at DG ECFIN of the European Commission (Brussels) and at the Hedge Fund Kairos Partners (London).
Mathematics and Economics graduate at Bocconi University and Université Catholique de Louvain (UCL) with focus on Marco-Growth Theory and Game Theory.
Fluent in English and Italian. Advanced speaker in French and Spanish. Basics of Portuguese and German.
This person is not in any teams
This person is not in any offices
Sandoz
27 followers
As a division of the Novartis Group, their purpose is to discover new ways to improve and extend people's lives. They contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.